{"id":"https://openalex.org/W2188916319","doi":null,"title":"Computer-aided estimation of pleiotropic effects of drugs","display_name":"Computer-aided estimation of pleiotropic effects of drugs","publication_year":2013,"publication_date":"2013-01-01","ids":{"openalex":"https://openalex.org/W2188916319","mag":"2188916319"},"language":"en","primary_location":{"id":"mag:2188916319","doi":null,"is_oa":false,"landing_page_url":"http://www.way2drug.org/PassOnline/downloads/articles/Lagunin-et-al-2013-MosBioTech.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000407608","display_name":"\u0410. \u0410. \u041b\u0430\u0433\u0443\u043d\u0438\u043d","orcid":"https://orcid.org/0000-0003-1757-8004","observed_orcids":["https://orcid.org/0000-0003-1757-8004"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lagunin \u0410.\u0410","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005302271","display_name":"Pavel V. Pogodin","orcid":"https://orcid.org/0000-0003-1843-7668","observed_orcids":["https://orcid.org/0000-0003-1843-7668"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pogodin P.V","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5026879705","display_name":"S Z Shatinina","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shatinina S.Z","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.12344281,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13013","display_name":"Free Radicals and Antioxidants","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pleiotropic-drug-effects","display_name":"pleiotropic drug effects","score":0.8159999847412109},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.7590000033378601},{"id":"https://openalex.org/keywords/pass-software","display_name":"PASS software","score":0.47099998593330383},{"id":"https://openalex.org/keywords/anxiolytics","display_name":"anxiolytics","score":0.8450000286102295},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":1.0},{"id":"https://openalex.org/keywords/perindopril","display_name":"perindopril","score":0.9629999995231628},{"id":"https://openalex.org/keywords/quinapril","display_name":"quinapril","score":0.9990000128746033},{"id":"https://openalex.org/keywords/combination-antihypertensive-therapy","display_name":"combination antihypertensive therapy","score":0.9769999980926514},{"id":"https://openalex.org/keywords/asthma","display_name":"asthma","score":0.9589999914169312},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.9800000190734863},{"id":"https://openalex.org/keywords/virtual-screening","display_name":"virtual screening","score":0.5910000205039978}],"concepts":[{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5421361327171326},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.495006263256073},{"id":"https://openalex.org/C2776120743","wikidata":"https://www.wikidata.org/wiki/Q3271540","display_name":"Mechanism of action","level":3,"score":0.4896755516529083},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4528055191040039},{"id":"https://openalex.org/C89611455","wikidata":"https://www.wikidata.org/wiki/Q6804646","display_name":"Mechanism (biology)","level":2,"score":0.4144706130027771},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.352311909198761},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3120388686656952},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2260650396347046},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.16356736421585083},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0},{"id":"https://openalex.org/C111472728","wikidata":"https://www.wikidata.org/wiki/Q9471","display_name":"Epistemology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2188916319","doi":null,"is_oa":false,"landing_page_url":"http://www.way2drug.org/PassOnline/downloads/articles/Lagunin-et-al-2013-MosBioTech.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.5683000087738037}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2799736077","https://openalex.org/W2044558167","https://openalex.org/W1498622539","https://openalex.org/W2011522317","https://openalex.org/W1652715","https://openalex.org/W2128672435","https://openalex.org/W4224950067","https://openalex.org/W6912309030","https://openalex.org/W2436510427","https://openalex.org/W1997999713"],"abstract_inverted_index":{"The":[0],"study":[1],"of":[2,5,19,22,25,32,50,53,60,63,75,79,96,104,115,137,159,162,166,174,194],"the":[3,17,20,30,33,58,61,102,111,119,172,183,191],"activity":[4,77],"many":[6],"effective":[7,189],"drugs":[8,37,161],"revealed":[9],"their":[10,84],"influence":[11],"on":[12,57,83,101],"several":[13],"targets,":[14],"and":[15,44,65,126,143,153,176],"identifying":[16],"mechanisms":[18],"pathogenesis":[21],"a":[23],"number":[24],"social":[26],"diseases":[27],"led":[28],"to":[29,35,109,130],"realization":[31],"need":[34],"develop":[36],"with":[38],"pleiotropic":[39,51,113],"actions.":[40],"We":[41],"have":[42],"developed":[43,184],"validated":[45],"methodology":[46,185],"for":[47,73,171],"computational":[48],"assessment":[49],"action":[52],"biologically":[54],"active":[55],"substances":[56],"basis":[59],"analysis":[62,95],"structureactivity":[64],"active-active":[66],"relationships.":[67],"Computer":[68,88],"program":[69,89],"PASS":[70,97],"is":[71,107,180,186],"used":[72,108],"prediction":[74,98],"biological":[76],"spectrum":[78],"chemical":[80,116,132],"compounds":[81,128],"based":[82,100],"structural":[85],"formula":[86],"[1].":[87],"PharmaExpert":[90],"[2],":[91],"which":[92],"provides":[93],"an":[94],"results":[99],"knowledge":[103],"mechanism-effect":[105],"relationships,":[106],"assess":[110],"potential":[112],"actions":[114],"compounds.":[117],"In":[118],"case":[120],"studies":[121],"we":[122],"identified:":[123],"anxiolytics,":[124],"anticonvulsants":[125],"nootropic":[127,148],"belonging":[129],"new":[131,134],"classes;":[133,164],"dual":[135],"inhibitors":[136],"angiotensin-converting":[138],"enzyme":[139],"/":[140,145],"neutral":[141],"endopeptidase":[142],"lipoxygenase":[144],"cyclooxygenase":[146],"1;":[147],"effect":[149],"in":[150],"perindopril,":[151],"quinapril":[152],"monopril;":[154],"preferred":[155],"clinically":[156],"relevant":[157],"combinations":[158],"antihypertensive":[160],"different":[163],"components":[165],"Hypericum":[167],"extracts,":[168],"potentially":[169],"responsible":[170],"manifestation":[173],"asthma":[175],"drug-drug":[177],"interactions.":[178],"It":[179],"shown":[181],"that":[182],"significantly":[187],"more":[188],"than":[190],"traditional":[192],"methods":[193],"virtual":[195],"screening.":[196]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}